Gapping up
In reaction to strong earnings/guidance:
- N/A.
M&A news:
- VERI +52.4% (Apis Capital submits all-cash offer to acquire all of the outstanding shares of Veritone for $10.26 per share)
- NTRI +27.2% (Tivity Health (TVTY) to acquire NTRI for $1.3 billion in cash and stock; transaction values NTRI at an enterprise value or $47.00/share)
- MDRX +2% (to sell its interests in Netsmart, netting after-tax proceeds of $525 million)
Select metals/mining stocks trading higher:
- BBL +1.8%, BHP +1.8%, AUY +1.3%, GOLD +1.2%, ABX +1.1%
Other news:
- MRNS +25.7% (positive results from its Phase 2 clinical trials evaluating ganaxolone intravenous and oral in women with postpartum depression)
- MITK +17.1% (ASG Technologies increases offer to $11.50 per share to acquire Mitek)
- RARX +15.4% ( announces positive top-line results from the Phase 2 clinical trial evaluating zilucoplan for the treatment of generalized myasthenia gravis)
- AKRX +3.5% (Akorn states that following the decision from the Supreme Court of the State of Delaware, a new CEO search is underway)
- BG +3.2% (confirms that CEO Soren Schroder will step down)
- LIN +2.5% (authorized a share repurchase program for up to $1.0 billion)
- YELP +2.1% (Yelp shareholder SQN Investors said to push for Board overhaul, review of strategic alternatives; issues statement, says maintains ongoing dialogue with all shareholders and broader investment community)
- NOK +1.6% (continued strength)
- GILD +1.6% (appoints Daniel O'Day Chairman and CEO)
Analyst comments:
- KTOS +10.7% (upgraded to Buy from Neutral at Goldman)
- FIVE +0.9% (upgraded to Buy from Hold at Loop Capital)
- X +0.7% (upgraded to Neutral from Sell at UBS)